-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Hc7h+xdRLGcGbBeD2RscoQYhSgkC0USW722h0FAqf4CJNsV3MCI+yNh17NqZRvK2 nXWDdWYiK6EjXcM+zs8MIw== 0000950144-05-000761.txt : 20050202 0000950144-05-000761.hdr.sgml : 20050202 20050202142824 ACCESSION NUMBER: 0000950144-05-000761 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20050127 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20050202 DATE AS OF CHANGE: 20050202 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMSURG CORP CENTRAL INDEX KEY: 0000895930 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 621493316 STATE OF INCORPORATION: TN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-22217 FILM NUMBER: 05568775 BUSINESS ADDRESS: STREET 1: 20 BURTON HILLS BLVD STREET 2: STE 350 CITY: NASHVILLE STATE: TN ZIP: 37215 BUSINESS PHONE: 6156651283 MAIL ADDRESS: STREET 1: ONE BURTON HILLS BLVD. STREET 2: SUITE 350 CITY: NASHVILLE STATE: TN ZIP: 37215 8-K 1 g93009e8vk.htm AMSURG CORP. Amsurg Corp.
Table of Contents



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 2, 2005 (January 27, 2005)

AMSURG CORP.

(Exact Name of Registrant as Specified in Charter)
         
Tennessee
(State or Other Jurisdiction of
Incorporation)
  000-22217
(Commission
File Number)
  62-1493316
(I.R.S. Employer
Identification No.)
     
20 Burton Hills Boulevard
Nashville, Tennessee

(Address of Principal Executive Offices)
  37215
(Zip Code)

(615) 665-1283

(Registrant’s Telephone Number, Including Area Code)

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     
o
  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
   
o
  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
   
o
  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
   
o
  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))



 


TABLE OF CONTENTS

Item 1.01. Entry Into a Material Definitive Agreement
Item 9.01. Financial Statements and Exhibits
SIGNATURES
INDEX TO EXHIBITS
Ex-99.1 Form of Non-Qualified Stock Option Agreement


Table of Contents

Item 1.01. Entry Into a Material Definitive Agreement

     On January 27, 2005, the Compensation Committee (the “Committee”) of the Board of Directors of AmSurg Corp. (the “Company”) approved certain resolutions, including resolutions with respect to the following actions:

     Approval of Stock Option Awards to Executive Officers and Others. The Committee granted options to purchase shares of the Company’s common stock to employees of the Company, including the executive officers of the Company, pursuant to the Company’s Amended and Restated 1997 Stock Incentive Plan, as amended. Stock options were granted to executive officers of the Company as follows:

             
        No. of Shares Subject
Name   Title   to Options Granted
Ken P. McDonald
  President and Chief Executive Officer     105,000  
Claire M. Gulmi
  Senior Vice President, Chief Financial Officer and Secretary     45,000  
David L. Manning
  Senior Vice President, Development     75,000  
Royce D. Harrell
  Senior Vice President, Corporate Services     37,500  

The form of Non-Qualified Stock Option Agreement for the options granted is attached hereto as Exhibit 99.1.

     Cash Bonus Plan. The Committee approved the Company’s Cash Bonus Plan for 2005. Pursuant to the 2005 Cash Bonus Plan, employees of the Company, including the executive officers, are eligible to receive cash bonuses based upon the Company’s attainment of certain earnings targets and other specific targets related to an employee’s specific area of responsibility, including surgery center profits and new acquisition and development transactions, in each case as determined by the Committee. For 2005, bonuses for Mr. McDonald and Ms. Gulmi will be based 50% upon the attainment of Company earnings targets, 33% upon targets related to surgery center profits, and 17% upon targets related to new acquisition and development transactions and Mr. Harrell’s bonus will be based 33% upon the attainment of Company earnings targets, 50% upon targets related to surgery center profits, and 17% upon targets related to new acquisition and development transactions. Mr. Manning is eligible to receive a cash bonus of up to 25% of his 2005 base salary based upon the attainment of Company earnings targets and up to 10% of his 2005 base salary based upon targets related to profits for newly acquired surgery centers. Mr. Manning is eligible to receive an additional cash bonus based upon the number of new acquisition and development transactions completed during 2005. The maximum total bonus award that executive officers can receive ranges from 60% to 100% of base salary for 2005.

     On January 28, 2005, the Board of Directors of the Company, upon the recommendation of the Committee, approved the terms of compensation to be paid to the non-employee directors of the Company. During 2005, each non-employee director will receive an annual retainer of $10,000 for his or her services as a director, $3,500 for each Board meeting that he or she attends in person and $1,500 for each Board meeting that he or she attends via telephone. Each non-employee director also will receive $1,000 for each meeting of the Compensation Committee or the Nominating and Corporate Governance Committee that he or she attends and $2,500 for each meeting of the Audit Committee that he or she attends, whether in person or via telephone, except that the Chair of the Audit Committee will receive $3,500 for each Audit Committee meeting that he attends, the Chair of the Compensation Committee will receive $2,000 for each Compensation Committee meeting that he attends and the Chair of the Nominating and Corporate Governance Committee will receive $2,000 for each Nominating and Corporate Governance Committee meeting that he attends. The Chairman of the Board of Directors will receive an additional $25,000 for his services as Chairman. In addition, the Company will reimburse each non-employee director for his or her out-of-pocket expenses incurred in attending Board of Directors’ meetings and committee meetings.

 


Table of Contents

     On the date of each annual meeting of shareholders, each non-employee director who is elected or reelected to the Board of Directors, or who otherwise continues as a director, will automatically receive on the date of the annual meeting of shareholders a grant of that number of shares of restricted common stock having an aggregate fair market value on such date equal to $10,000, adjusted annually for changes in the Consumer Price Index, or CPI. Each grant of restricted stock will vest in equal one-third increments on the date of grant and, if the grantee is still a director, the first and second anniversaries of the date of grant. Until the earlier of (i) five years from the date of grant and (ii) the date on which the non-employee director ceases to serve as a director, no restricted stock may be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated, other than by will or by the laws of descent and distribution. Upon termination of a non-employee director’s service as a director for any reason other than death, disability or retirement, all shares of his or her unvested restricted stock will be forfeited. Upon termination of a non-employee director’s service as a director due to death, disability or retirement, all shares of his or her restricted stock will vest immediately.

Item 9.01. Financial Statements and Exhibits

     (c) Exhibit 99.1 – Form of Non-Qualified Stock Option Agreement

 


Table of Contents

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    AMSURG CORP.
 
       
  By:   /s/ Claire M. Gulmi
       
      Claire M. Gulmi
Senior Vice President, Chief Financial Officer and Secretary (Principal Financial and Duly Authorized Officer)
 
       
Date: February 2, 2005
       

3


Table of Contents

INDEX TO EXHIBITS

     
Exhibit    
Number   Description
99.1
  Form of Non-Qualified Stock Option Agreement

4

EX-99.1 2 g93009exv99w1.txt EX-99.1 FORM OF NON-QUALIFIED STOCK OPTION AGREEMENT EXHIBIT 99.1 NON-QUALIFIED STOCK OPTION AGREEMENT THIS STOCK OPTION AGREEMENT is made and entered into this ___ day of _________, _____, by and between AMSURG CORP., a Tennessee corporation (the "Corporation"), and _______________________ ("the Colleague"). WHEREAS, the Corporation desires to afford the Colleague an opportunity to purchase shares of Common Stock, no par value per share ("Common Stock") of the Corporation, in accordance with the provisions of the AmSurg Corp. 1997 Stock Incentive Plan, as amended (the "Plan"). NOW, THEREFORE, in consideration of the mutual covenants set forth in this Agreement and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows: 1. GRANT OF OPTION. Corporation hereby grants to Colleague the option (the "Option"), exercisable in whole or in part, to purchase ________ shares of the Corporation's Common Stock, for a price of $_______ per share. 2. OPTION PLAN. This Option is granted as a non-qualified stock option under the Plan, and is not intended to qualify as an incentive stock option, as that term is used in Section 422 of the Internal Revenue Code of 1986, as amended (the "Code"). This means that, at the time Colleague exercises all or any portion of this Option, Colleague will have taxable income equal to any positive difference between the market value of the Common Stock at the date of the exercise and the option exercise price paid for the Common Stock under this Option as shown in Section 1 of this agreement. This Option is subject to the terms and conditions set forth in the Plan. In the event any of the provisions in this Agreement conflict with or are inconsistent with the provisions of the Plan, the provisions of the Plan shall be controlling. 3. TIMING OF EXERCISE. Colleague may exercise this Option with respect to the percentage of shares set forth below from and after the dates specified below:
CUMULATIVE PERCENTAGE VESTED DATE OF VESTING OPTIONS EXERCISABLE 20% ------------- ---------------- 40% ------------- ---------------- 60% ------------- ---------------- 80% ------------- ---------------- 100% ------------- ----------------
This Option will expire ten (10) years from the date of grant of this Option. 4. MANNER OF EXERCISE. This Option shall be exercised by the Colleague (or other party entitled to exercise the Option under Section 6 of this Agreement) by delivering written notice to the Corporation stating the number of shares of Common Stock to be purchased, the person or persons in whose name the shares are to be registered and each such person's address and social security number. Such notice shall not be effective unless accompanied by the full purchase price for all shares so purchased. The purchase price shall be payable in cash, in unrestricted shares of common stock held by the Colleague for at least six months prior to the date of exercise or any combination thereof and shall be calculated as the number of shares to be purchased times the option exercise price per share as shown in Section 1 of this Agreement. Payment in currency or by certified check, cashier's check or postal money order shall be considered payment in cash. The Corporation shall have the right to require the Colleague to remit to the Corporation an amount sufficient to satisfy any federal, state and local withholding tax requirements prior to the delivery of any certificate for such shares. 5. NONTRANSFERABILITY OF OPTION. This Option shall not be transferable by the Colleague other than transfers by the Colleague to a member of his or her Immediate Family or a trust for the benefit of the Colleague or a member of his or her Immediate Family or transfers by will, and is exercisable during Colleague's lifetime only by the Colleague. The terms of this Option shall be binding on the executors, administrators, heirs and successors of the Colleague. 6. TERMINATION OF EMPLOYMENT. (a) TERMINATION BY DEATH. If the Colleague's employment by the Corporation terminates by reason of death, this Option may thereafter be exercised, to the extent the Option was exercisable at the time of death, by the legal representative of the estate or by the legatee of the Colleague under the will of the Colleague, for a period of twelve (12) months from the date of such death or until the expiration of the stated term of the Option, whichever period is the shorter. (b) TERMINATION BY REASON OF DISABILITY. If the Colleague's employment by the Corporation terminates by reason of Disability, this Option may thereafter be exercised by the Colleague, to the extent it was exercisable at the time of termination, for a period of three (3) years from the date of such termination of employment or until the expiration of the stated term of the Option, whichever period is shorter, provided, however, that if the Colleague dies within such three (3) year period, the Option shall thereafter be exercisable to the extent to which it was exercisable at the time of death for a period of twelve (12) months from the date of such death or until the expiration of the stated term of the Option, whichever period is shorter. (c) TERMINATION BY REASON OF RETIREMENT. If the Colleague's employment by the Corporation terminates by reason of Retirement, this Option to the extent not previously exercisable and vested shall become fully exercisable and vested and may thereafter be exercised by Colleague until the expiration of the stated term of this Option, provided, however, that if the Colleague dies within such period, the Option shall thereafter be exercisable to the extent to which it was exercisable at the time of death for a period of twelve (12) months from the date of such death or until the expiration of the stated term of the Option, whichever period is shorter. (d) OTHER TERMINATION. If the Colleague's employment by the Corporation terminates for any reason other than death, Disability or Retirement, this Option shall thereupon terminate, except that this Option may be exercised by the Colleague, to the extent otherwise then exercisable, for a period of three (3) months from the date of such termination of employment or the expiration of the Option's term, whichever period is the shorter. 7. RESTRICTIONS ON PURCHASE AND SALE OF SHARES. The Corporation shall be obligated to sell or issue shares pursuant to the exercise of this Option only in the event that the shares are at that time effectively registered or otherwise exempt from registration under the Securities Act of 1933, as amended ("the 1933 Act"). In the event that the shares are not registered under the 1933 Act, the Colleague hereby agrees that, as a further condition to the exercise of this Option, the Colleague (or his successor under Section 6 of this Agreement), if the Corporation so requests, will execute an agreement in form satisfactory to the Corporation in which the Colleague represents that he or she is purchasing the shares for investment purposes, and not with a view to resale or distribution. The Colleague further agrees that if the shares of Common Stock to be issued upon the exercise of this Option are not subject to an effective registration statement filed with the Securities and Exchange Commission pursuant to the requirements of the 1933 Act, such shares shall bear an appropriate restrictive legend. 8. CHANGE OF CONTROL OR POTENTIAL CHANGE OF CONTROL. In the event of a Change of Control as such term is defined in the Plan, this Option to the extent not previously exercisable and vested shall become fully exercisable and vested. 9. ADJUSTMENT. In the event of any merger, reorganization, consolidation, recapitalization, extraordinary cash dividend, stock dividend, stock split or other change in corporate structure affecting the Common Stock, the number of shares of Common Stock of the Corporation subject to this Option and the price per share of such shares may be adjusted by the Corporation as may be determined by the Compensation Committee of the Corporation's Board of Directors (the "Committee") pursuant to the Plan. 10. NO RIGHTS UNTIL EXERCISE. The Colleague shall have no rights hereunder as a shareholder with respect to any shares subject to this Option until the date of the issuance of a stock certificate to him or her for such shares upon due exercise of this Option. 11. RESTRICTIVE COVENANTS. It is in the best interest of all Colleagues to protect and preserve the assets of the Corporation. In this regard, in consideration for granting this Option and as conditions to Colleague's ability to exercise this Option, Colleague acknowledges and agrees that: (a) CONFIDENTIALITY. In the course of Colleague's employment, Colleague will have access to trade secrets and other confidential information of the Corporation and its associated partnerships, limited liability companies and physician partners ("Affiliates"). Accordingly, Colleague agrees that, without the prior written consent of the Corporation, Colleague will not, other than in the normal conduct of the Corporation's business affairs, divulge, furnish, publish or use for personal benefit or for the direct or indirect benefit of any other person or business entity, whether or not for monetary gain, any trade secrets or confidential or proprietary information of the Corporation or its Affiliates, including without limitation, any information relating to any business methods, marketing and business plans, financial data, systems, customers, suppliers, policies, procedures, techniques or research developed for the benefit of the Corporation or its Affiliates. Proprietary information includes, but is not limited to, information developed by the Colleague for the Corporation while employed by the Corporation. The obligations of the Colleague under this paragraph will continue without expiration after the Colleague has left the employment of the Corporation. Colleague agrees that upon leaving the employment of the Corporation, Colleague will return to the Corporation all property and confidential information in the Colleague's possession and agrees not to copy or otherwise record in any way such information. (b) NON-SOLICITATION. While employed by the Corporation and for a period of two (2) years thereafter, Colleague shall not, upon Colleague's own behalf or on behalf of any other person or entity, directly or indirectly, (i) hire or solicit to leave the employ of the Corporation any person employed by or under contract as an independent contractor to the Corporation; or (ii) contact, solicit, entice away, or divert any business from any person or entity who is an Affiliate or with whom the Corporation was engaged in discussions as a potential Affiliate within one (1) year prior to the date of termination of Colleague. In the event Colleague breaches any provisions of this paragraph, this Option shall immediately terminate and may not be exercised and the Corporation shall be entitled to seek other appropriate remedies it may have available to limit its damages from such breach. 12. AMENDMENT. The Committee may amend the terms of this Option, prospectively or retroactively, but, subject to Section 9 above, no such amendment shall impair the rights of the Colleague hereunder without the Colleague's consent. 13. NOTICES. All notices required to be given under this Option shall be deemed to be received if delivered or mailed as provided for herein, to the parties at the following addresses, or to such other address as either party may provide in writing from time to time. To the Corporation: AmSurg Corp. 20 Burton Hills Boulevard Nashville, Tennessee 37215 To the Colleague: ---------------------------- ---------------------------- ---------------------------- IN WITNESS WHEREOF, the parties have caused the Stock Option Agreement to be duly executed as of the day and year first above written. AMSURG CORP. By: -------------------------------------- Title: ------------------------------- Colleague: ------------------------------- Name: ------------------------------------
-----END PRIVACY-ENHANCED MESSAGE-----